Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription Articles published in Clin Exp Immunol Retrieve available abstracts of 9 articles: HTML format

Single Articles

August 2023
1. DEVAN J, Nosi V, Spagnuolo J, Chancellor A, et al
   Surface protein and functional analyses identify CD4+CD39+ TCR alphabeta+ and activated TCR Vdelta1+ cells with distinct pro-inflammatory functions in Crohn's Disease lesions.
   Clin Exp Immunol. 2023 Aug 16:uxad098. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. SEIDELIN JB, Jensen S, Hansen M, Bronze MRC, et al
   IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease.
   Clin Exp Immunol. 2023 Aug 16:uxad092. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. LUTTER L, Ter Linde JJM, Brand EC, Hoytema van Konijnenburg DP, et al
   Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.
   Clin Exp Immunol. 2023 Aug 11:uxad095. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2022
4. HU M, Chen Z, Liao Y, Wu J, et al
   Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn's disease.
   Clin Exp Immunol. 2022;209:311-315.
   PubMed     Abstract available
   
   
   June 2022
5. MA K, Que W, Hu X, Guo WZ, et al
   Combinations of anti-GITR antibody and CD28 superagonist ameliorated dextran sodium sulfate-induced mouse colitis.
   Clin Exp Immunol. 2022;208:340-350.
   PubMed     Abstract available
   
   
   
6. SHARIFINEJAD N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, et al
   The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
   Clin Exp Immunol. 2022;208:281-291.
   PubMed     Abstract available
   
   
   May 2021
7. QIAN K, Yuan L, Wang S, Kuang Y, et al
   Inhibitor of apoptosis stimulating p53 protein (iASPP) protects against inflammatory bowel disease (IBD) in mice models by inhibiting the NF-kappaB signaling.
   Clin Exp Immunol. 2021 May 3. doi: 10.1111/cei.13613.
   PubMed     Abstract available
   
   
   February 2021
8. LAN X, Liu F, Ma J, Chang Y, et al
   Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator.
   Clin Exp Immunol. 2021;203:286-303.
   PubMed     Abstract available
   
   
   June 2020
9. SHAMRIZ O, Simon AJ, Lev A, Megged O, et al
   Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
   Clin Exp Immunol. 2020;200:215-227.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.